Black women more likely to be diagnosed with late stage breast cancer than white women

November 15, 2016

Black African women are nearly twice as likely to be diagnosed with late stage breast cancer as white women in England according to new analysis* from Cancer Research UK and Public Health England released today (Wednesday).

Twenty five per cent of Black African women and 22 per cent of Black Caribbean women diagnosed with breast cancer are picked up at stage three and four.

This compares to thirteen per cent of white British women.

This is the first time data on more specific ethnic groups and their stage at diagnosis from across England has been routinely released, helping to build a clearer picture of who is diagnosed at an early or late stage.

Ethnicity and stage at diagnosis was collected for women diagnosed with breast cancer in England in 2012 and 2013**.

Dr Jodie Moffat, Cancer Research UK's head of early diagnosis, said: "Information about the stage when cancers are diagnosed in the UK has greatly improved in recent years, and it's vital the data continues to be collected and analysed. While there are still gaps, this information provides a useful insight into which ethnic groups are more likely to be diagnosed with late stage cancer. It's difficult to know exactly what would be behind any differences, but there are likely to be a range of reasons, including possible differences in tumour biology, awareness of symptoms, barriers to seeking help, attitudes to cancer and breast screening attendance.

Dr Jem Rashbass, PHE Cancer Lead, said: "This analysis will help improve awareness and target treatments. It also shows how vital it is that we collect data is on every person with cancer England, as findings like these are only possible due to the world leading cancer data we have in this country.

"It is hugely important to catch all cancers, but particularly breast cancer, early. Lumps are not the only sign and women should tell their GP if they notice any changes to their breasts such as nipple discharge or changes to the skin of the breast. Breast screening is offered to women aged 50-70 and can help detect cancer earlier and improve survival."

Dr Julie Sharp, Cancer Research UK's head of health information, said: "Reducing late stage diagnosis of cancer is a key part of our work to achieve better results for patients, and we want to be sure that any activity is reaching those most in need. Because of the data gaps, we'll need further work to know how accurate the picture is that these results paint. But we are clear that finding cancer at an earlier stage can make a real difference as it means treatment is more likely to be successful. If you notice something that isn't normal for you, or you've a symptom that's not gone away or has got worse, getting it checked out promptly could save your life."
-end-


Cancer Research UK

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.